SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,000 | -20.0% | 730 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $5,000 | -28.6% | 730 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $7,000 | -22.2% | 730 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $9,000 | 0.0% | 730 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $9,000 | -18.2% | 730 | 0.0% | 0.00% | -40.0% |
Q4 2020 | $11,000 | +83.3% | 730 | +12.3% | 0.01% | +66.7% |
Q3 2020 | $6,000 | 0.0% | 650 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $6,000 | -91.2% | 650 | -93.9% | 0.00% | -93.3% |
Q1 2020 | $68,000 | +1260.0% | 10,650 | +1538.5% | 0.04% | +1400.0% |
Q4 2019 | $5,000 | -16.7% | 650 | 0.0% | 0.00% | -25.0% |
Q3 2019 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $7,000 | +16.7% | 650 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $6,000 | -14.3% | 650 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $7,000 | -22.2% | 650 | 0.0% | 0.01% | -16.7% |
Q3 2018 | $9,000 | 0.0% | 650 | 0.0% | 0.01% | -14.3% |
Q2 2018 | $9,000 | -25.0% | 650 | 0.0% | 0.01% | -22.2% |
Q1 2018 | $12,000 | – | 650 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |